 |
|
Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
Miyeon Kim, Hwa Young Lee, Hyunwoo Kim
Korean J Intern Med. 2025;40(3):468-481. Published online 2025 Apr 30 DOI: https://doi.org/10.3904/kjim.2024.160
|
|
Citations to this article as recorded by
 Left Ventricular Hypertrophy in Chronic Kidney Disease: Prevalence and Association With Renal Function Parameters
I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, Zh. A. Murkamilova, Z. R. Rayimzhanov, Sh. Sh. Khakimov, Zh. I. Solizhonov, Sh. E. Umurzakov, F. A. Yusupov, T. F. Yusupova, O. T. Zakirov, K. A. Gassanov, K. K. Khabibullaev, D. S. Ymankulov, I. A. Abdibaliev
Kardiologiia.2026; 66(3): 36. CrossRef Association of ACEIs/ARBs treatment with clinical outcomes in acute kidney injury: a multicenter retrospective cohort analysis
Hai Wang, Ji Zhao, Jun-hua Lv, Zheng-hai Bai, Hong-hong Pei
BMC Pharmacology and Toxicology.2026;[Epub] CrossRef Efficacy and Safety of Baxdrostat in Hypertension: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials
Muhammad Burhan, Zain Ul Abideen Shahid, Muhammad Abdullah Naveed, Nitin Wathore, Ziyan Ansari, Taha Ibrahim, Syed Huzaifa Alam Raza, Malika Abidi, Ayesha Irshad, Shiva Kumar, Saad Ashraf, Zoya Ansari, Mudassir Shahnawaz, Urooj Sheraz, Muhammad Salaar Ria
Annals of Pharmacotherapy.2026;[Epub] CrossRef
|